MedPath

Effectiveness of Yavagodhumadi Upanaha Swedana in comperison to Koladi Upanaha Swedana and 1% topical Diclofenac gel in Janu Sandhigatavata (Osteoarthritis of knee)

Phase 3
Conditions
Health Condition 1: M179- Osteoarthritis of knee, unspecified
Registration Number
CTRI/2022/04/041630
Lead Sponsor
Abhishek Bhattacharjee
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient who are willing to participate in the study and ready to give a written informed consent.

2.Subjects of either sex in the age group of 40 to 60 years.

3.Patients with a diagnosis of knee Osteoarthritis as per American College of Rheumatology clinical and radiographic criteria.

4.Knee Osteoarthritis confirmed by radiological changes as per Kellgren & Lawrence radiological scale of at least grade 2 in X-ray.

5.Osteoarthritis Patients with mean baseline pain intensity of 4 in Visual Analogue Scale (VAS) of 10 in one or both knees.

Exclusion Criteria

1.The subjects who are known to have congenital dysplasia, gouty arthritis, rheumatoid arthritis, psoriatic arthritis and other autoimmune diseases, malignancies, history of any trauma or fractured joint or surgical history to the joint.

2.Patients with gross disability in performing daily normal routine i.e., bedridden subjects or confined to a wheelchair, having any deformity of knee, hip or back altering the gait and posture.

3.Patient who has been administered any chondroprotective drugs, intra-articular injection into the affected knee joint or invasive measures have been performed at the affected joint or systemic medication with corticosteroids during the preceding 3 months.

4.Patients on medication likely to influence evaluation.

5.Pregnant or lactating women

6.Patients with an acute mental disorder, a serious acute organic disease, or any serious comorbidity that made it impossible to participate in the trial interventions.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
WOMAC questionnaire for pain and physical functionTimepoint: 0- day, 15th day, 30th day
Secondary Outcome Measures
NameTimeMethod
1. Visual analogue scale (VAS) score for pain and stiffness. <br/ ><br>3. 30 (thirty) second chair stand test <br/ ><br>4. 40 (forty) meter (4x10 meter) fast-paced walk test <br/ ><br>5. Timed up and go test <br/ ><br>6. 6 (six) minute walk test <br/ ><br>7. Stair climb test <br/ ><br>8. Goniometric measurement of the range of movement of knee joint <br/ ><br>9. Knee circumference <br/ ><br>Timepoint: 0- day, 15th day, 30th day
© Copyright 2025. All Rights Reserved by MedPath